|
1
|
Hoette S, Jardim C and Souza Rd: Diagnosis
and treatment of pulmonary hypertension: An update. J Bras Pneumol.
36:795–811. 2010.(In English, Portuguese). View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shi Y, Wang C, Han S, Pang B, Zhang N,
Wang J and Li J: Determination of PKC isoform-specific protein
expression in pulmonary arteries of rats with chronic
hypoxia-induced pulmonary hypertension. Med Sci Monit.
18:BR69–BR75. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nie X, Shi Y, Yu W, Xu J, Hu X and Du Y:
Phosphorylation of PTEN increase in pathological right ventricular
hypertrophy in rats with chronic hypoxia induced pulmonary
hypertension. Chin Med J (Engl). 127:338–342. 2014.PubMed/NCBI
|
|
4
|
McLaughlin VV, Archer SL, Badesch DB,
Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH,
Rosenson RS, et al: ACCF/AHA 2009 expert consensus document on
pulmonary hypertension a report of the American College of
Cardiology Foundation Task Force on Expert Consensus Documents and
the American Heart Association developed in collaboration with the
American College of Chest Physicians; American Thoracic Society,
Inc.; and the pulmonary hypertension association. J Am Coll
Cardiol. 53:1573–1619. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang S, Wang Y, Jiang J, Wang R, Li L, Qiu
Z, Wu H and Zhu D: 15-HETE protects rat pulmonary arterial smooth
muscle cells from apoptosis via the PI3K/Akt pathway.
Prostaglandins Other Lipid Mediat. 91:51–60. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hurley JH, Newton AC, Parker PJ, Blumberg
PM and Nishizuka Y: Taxonomy and function of C1 protein kinase C
homology domains. Protein Sci. 6:477–480. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nitti M, Pronzato MA, Marinari UM and
Domenicotti C: PKC signaling in oxidative hepatic damage. Mol
Aspects Med. 29:36–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fan HC, Fernandez-Hernando C and Lai JH:
Protein kinase C isoforms in atherosclerosis: Pro- or
anti-inflammatory? Biochem Pharmacol. 88:139–149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Haller H, Baur E, Quass P, Behrend M,
Lindschau C, Distler A and Luft FC: High glucose concentrations and
protein kinase C isoforms in vascular smooth muscle cells. Kidney
Int. 47:1057–1067. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Webb BL, Lindsay MA, Seybold J, Brand NJ,
Yacoub MH, Haddad EB, Barnes PJ, Adcock IM and Giembycz MA:
Identification of the protein kinase C isoenzymes in human lung and
airways smooth muscle at the protein and mRNA level. Biochem
Pharmacol. 54:199–205. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Newton AC: Protein kinase C: Structure,
function, and regulation. J Biol Chem. 270:28495–28498. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Throckmorton DC, Packer CS and Brophy CM:
Protein kinase C activation during Ca2+-independent
vascular smooth muscle contraction. J Surg Res. 78:48–53. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang H, Okamoto M, Panzhinskiy E, Zawada
WM and Das M: PKCδ/midkine pathway drives hypoxia-induced
proliferation and differentiation of human lung epithelial cells.
Am J Physiol Cell Physiol. 306:C648–C658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Agbani EO, Coats P, Mills A and Wadsworth
RM: Peroxynitrite stimulates pulmonary artery endothelial and
smooth muscle cell proliferation: Involvement of ERK and PKC. Pulm
Pharmacol Ther. 24:100–109. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mandegar M, Fung YC, Huang W, Remillard
CV, Rubin LJ and Yuan JX: Cellular and molecular mechanisms of
pulmonary vascular remodeling: Role in the development of pulmonary
hypertension. Microvasc Res. 68:75–103. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamamoto M, Acevedo-Duncan M, Chalfant CE,
Patel NA, Watson JE and Cooper DR: The roles of protein kinase C
beta I and beta II in vascular smooth muscle cell proliferation.
Exp Cell Res. 240:349–358. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu BH, Yao ZX, Luo SJ, Jiang LM, Xiao JW,
Liu SC, Liu JB, Sun JM and Pei ZY: Effects of antisense
oligonucleotides of PKC-alpha on proliferation and apoptosis of
HepG2 in vitro. Hepatobiliary Pancreat Dis Int. 4:75–79.
2005.PubMed/NCBI
|
|
18
|
Sasaguri T, Kosaka C, Hirata M, Masuda J,
Shimokado K, Fujishima M and Ogata J: Protein kinase C-mediated
inhibition of vascular smooth muscle cell proliferation: The
isoforms that may mediate G1/S inhibition. Exp Cell Res.
208:311–320. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pisarcik S, Maylor J, Lu W, Yun X, Undem
C, Sylvester JT, Semenza GL and Shimoda LA: Activation of
hypoxia-inducible factor-1 in pulmonary arterial smooth muscle
cells by endothelin-1. Am J Physiol Lung Cell Mol Physiol.
304:L549–L561. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li XW, Hu CP, Wu WH, Zhang WF, Zou XZ and
Li YJ: Inhibitory effect of calcitonin gene-related peptide on
hypoxia-induced rat pulmonary artery smooth muscle cells
proliferation: Role of ERK1/2 and p27. Eur J Pharmacol.
679:117–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ripple MO, Kim N and Springett R: Acute
mitochondrial inhibition by mitogen-activated protein
kinase/extracellular signal-regulated kinase kinase (MEK) 1/2
inhibitors regulates proliferation. J Biol Chem. 288:2933–2940.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Preston IR, Hill NS, Warburton RR and
Fanburg BL: Role of 12-lipoxygenase in hypoxia-induced rat
pulmonary artery smooth muscle cell proliferation. Am J Physiol
Lung Cell Mol Physiol. 290:L367–L374. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li GW, Xing WJ, Bai SZ, Hao JH, Guo J, Li
HZ, Li HX, Zhang WH, Yang BF and Wu LY: The calcium-sensing
receptor mediates hypoxia-induced proliferation of rat pulmonary
artery smooth muscle cells through MEK1/ERK1,2 and PI3K pathways.
Basic Clin Pharm Toxicol. 108:185–193. 2011. View Article : Google Scholar
|
|
24
|
Wang P, Xu J, Hou Z, Wang F, Song Y, Wang
J, Zhu H and Jin H: miRNA-34a promotes proliferation of human
pulmonary artery smooth muscle cells by targeting PDGFRA. Cell
Prolif. 49:484–493. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barman SA, Zhu S and White RE: Protein
kinase C inhibits BKCa channel activity in pulmonary arterial
smooth muscle. Am J Physiol Lung Cell Mol Physiol. 286:L149–L155.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dempsey EC, Badesch DB, Dobyns EL and
Stenmark KR: Enhanced growth capacity of neonatal pulmonary artery
smooth muscle cells in vitro: Dependence on cell size, time from
birth, insulin-like growth factor I, and auto-activation of protein
kinase C. J Cell Physiol. 160:469–481. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dempsey EC, Frid MG, Aldashev AA, Das M
and Stenmark KR: Heterogeneity in the proliferative response of
bovine pulmonary artery smooth muscle cells to mitogens and
hypoxia: Importance of protein kinase C. Can J Physiol Pharmacol.
75:936–944. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang HP, Xu YJ, Zhang ZX, Ni W and Chen
SX: Effect of protein kinase C-nuclear factor-kappa B signal
transduction pathway on proliferation and expression of vascular
endothelial growth factor in human pulmonary artery smooth muscle
cells. Zhonghua Jie He He Hu Xi Za Zhi. 27:218–223. 2004.PubMed/NCBI
|
|
29
|
Jin N, Hatton N, Swartz DR, Xia Xl,
Harrington MA, Larsen SH and Rhoades RA: Hypoxia activates
jun-N-terminal kinase, extracellular signal-regulated protein
kinase, and p38 kinase in pulmonary arteries. Am J Respir Cell Mol
Biol. 23:593–601. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Weerackody RP, Welsh DJ, Wadsworth RM and
Peacock AJ: Inhibition of p38 MAPK reverses hypoxia-induced
pulmonary artery endothelial dysfunction. Am J Physiol Heart Circ
Physiol. 296:H1312–H1320. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Church AC, Martin DH, Wadsworth R, Bryson
G, Fisher AJ, Welsh DJ and Peacock AJ: The reversal of pulmonary
vascular remodeling through inhibition of p38 MAPK-alpha: A
potential novel anti-inflammatory strategy in pulmonary
hypertension. Am J Physiol Lung Cell Mol Physiol. 309:L333–L347.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun Y, Tian Y, Prabha M, Liu D, Chen S,
Zhang R, Liu X, Tang C, Tang X, Jin H and Du J: Effects of sulfur
dioxide on hypoxic pulmonary vascular structural remodeling. Lab
Invest. 90:68–82. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xia S, Tai X, Wang Y, An X, Qian G, Dong
J, Wang X, Sha B, Wang D, Murthi P, et al: Involvement of Gax gene
in hypoxia-induced pulmonary hypertension, proliferation, and
apoptosis of arterial smooth muscle cells. Am J Respir Cell Mol
Biol. 44:66–73. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang B, Shen M, Xu M, Liu LL, Luo Y, Xu
DQ, Wang YX, Liu ML, Liu Y, Dong HY, et al: Role of macrophage
migration inhibitory factor in the proliferation of smooth muscle
cell in pulmonary hypertension. Mediators Inflamm. 2012:8407372012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Park MJ, Park IC, Lee HC, Woo SH, Lee JY,
Hong YJ, Rhee CH, Lee YS, Lee SH, Shim BS, et al: Protein kinase
C-alpha activation by phorbol ester induces secretion of gelatinase
B/MMP-9 through ERK 1/2 pathway in capillary endothelial cells. Int
J Oncol. 22:137–143. 2003.PubMed/NCBI
|
|
36
|
Okazaki J, Mawatari K, Liu B and Kent KC:
The effect of protein kinase C and its alpha subtype on human
vascular smooth muscle cell proliferation, migration and
fibronectin production. Surgery. 128:192–197. 2000. View Article : Google Scholar : PubMed/NCBI
|
